Meritz Financial Group (XKRX:138040) Research & Development: ₩0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:138040 Meritz Financial Group XKRX:138040
44 GF Score
Price ₩120,300.00
GF Value ₩105,707.28
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Meritz Financial Group Research & Development?

Meritz Financial Group XKRX:138040 -2.98% 44 Research & Development is ₩0 Mil as of Mar. 2026. GuruFocus rates XKRX:138040 with a GF Score™ of 44/100 and a GF Value™ of ₩105,707.28 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Meritz Financial Group's Research & Development for the three months ended in Mar. 2026 was ₩0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₩0 Mil.

Meritz Financial Group  (XKRX:138040) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Meritz Financial Group Research & Development Related Terms

Meritz Financial Group Research & Development Historical Data

* Premium members only.

The historical data trend for Meritz Financial Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meritz Financial Group Research & Development Chart

Meritz Financial Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Meritz Financial Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKRX:138040
44GF Score
Meritz Financial Group XKRX:138040
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meritz Financial Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₩0 Mil mean?
Meritz Financial Group (XKRX:138040) has a Research & Development of ₩0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Meritz Financial Group and its competitors.
Is Meritz Financial Group's Research & Development too high?
Meritz Financial Group's current Research & Development is ₩0 Mil. Overall, Meritz Financial Group has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Meritz Financial Group's Research & Development compare to MS and GS?
Meritz Financial Group's Research & Development of ₩0 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Meritz Financial Group and its competitors. Meritz Financial Group's current Research & Development is ₩0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meritz Financial Group stock overvalued right now?
Based on GuruFocus' analysis, Meritz Financial Group (XKRX:138040) is currently considered Modestly Overvalued. The stock's GF Value™ is ₩105,707.28, compared to a current price of ₩120,300.00 — trading 13.8% above its estimated fair value. The current Research & Development is ₩0 Mil. Meritz Financial Group's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Meritz Financial Group (XKRX:138040), the current Research & Development is ₩0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Meritz Financial Group (XKRX:138040) Overvalued in 2026?

Based on GuruFocus' analysis, Meritz Financial Group stock appears to be overvalued. The current stock price of ₩120,300.00 is trading 13.8% above its estimated GF Value™ of ₩105,707.28. GuruFocus considers Meritz Financial Group to be Modestly Overvalued.

Key valuation signals for XKRX:138040:

  • Research & Development: ₩0 Mil
  • GF Value™: ₩105,707.28 vs. price of ₩120,300.00 (13.8% above fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the XKRX:138040 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Meritz Financial Group Business Description

Address 382 Gangnam-daero, Gangnam-gu, Seoul, KOR, 06232
Meritz Financial Group provides various financial services in South Korea and internationally. It operates through Insurance, Securities, Capital, and Others segments. It provides a wide range of non-life insurance products, including fire, marine, accident, engineering, liability, auto, and various long-term insurance plans covering damage, health, savings, and pensions. In addition to insurance, the company operates in merchant banking, securities, private equity, trust management, real estate leasing, and asset-securitization services. It generates the majority of its revenue from the Securities segment.
44GF Score

Get the complete analysis for XKRX:138040

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩120,300.00
Price
₩105,707.28
GF Value